Home›Stocks›KYKOF

KYKOF — structural market context

Kyowa Hakko Kogyo Ordinary Sha

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

KYKOF short interest & days to cover

SHARES SHORT
3.1M
% OF FLOAT
—
DAYS TO COVER
1000.0
CHANGE VS PRIOR
+16.2%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (41d ago)

KYKOF analyst ratings — with each firm's measured accuracy

FirmActionRatingFirm 5d hit rate*Published
JefferiesdowngradeHold53.3% (n=30)2026-09-08

*Rating actions from public feeds. Where shown, the firm's 5-day hit rate is our measured backtest (firms with >=30 graded calls); a historical hit rate describes past calls, it does not grade this one.

Frequently asked questions

What do analysts say about KYKOF?
The most recent action: Jefferies downgrade to Hold on 2026-09-08. In our backtest, Jefferies's 5-day hit rate across 30 graded calls is 53.3%. We show each firm's measured record next to its ratings; a historical hit rate describes past calls and does not grade this one.
Is this page telling me to buy or sell KYKOF?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with K

KDP · Keurig Dr Pepper Inc. Common SKHNGY · Kuehne & Nagel International AKIDS · OrthoPediatrics Corp. Common SKKR · KKR & Co. Inc.KR · The Kroger Co.KRYS · Krystal Biotech, Inc. Common SAll K →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.